India News | Press Trust of India | Wednesday July 31, 2024
Omaxe will consider challenging market regulator SEBI's order that barred the firm, its Chairman Rohtas Goel, MD Mohit Goel and three others from the securities market for two years for misrepresentation in the company's financial statements.
www.ndtv.com